Schizophrenia and substance use comorbidity: a genome-wide perspective

Dual diagnosis with substance use disorders (SUDs) consistently contributes to the premature mortality and increased disability observed in schizophrenia. Large genome-wide association studies are providing the information needed to investigate the genetic architecture of psychiatric disorders. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Polimanti, Renato, Agrawal, Arpana, Gelernter, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359801/
https://www.ncbi.nlm.nih.gov/pubmed/28327175
http://dx.doi.org/10.1186/s13073-017-0423-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359801/
https://www.ncbi.nlm.nih.gov/pubmed/28327175
http://dx.doi.org/10.1186/s13073-017-0423-3

Ejemplares similares